Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
55 Years to 80 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients with fragility fracture according to the diagnostic criterial for the diagnosis of Primary Osteoporosis
Patients having radiographically confirmed vertebral (T4-L4) fractures
Other inclusion criteria as specified in the study protocol
Patients having secondary osteoporosis or another condition that presents low bone mass
Patients having findings on X-ray that affect evaluation of vertebral fracture
Patients that have been administered bisphosphonate derivatives
Other exclusion criteria as specified in the study protocol